Bruker ROA 2010-2023 | BRKR
Current and historical return on assets (ROA) values for Bruker (BRKR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Bruker ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2023-12-31 |
$0.43B |
$4.25B |
10.91% |
| 2023-09-30 |
$0.32B |
$3.82B |
8.48% |
| 2023-06-30 |
$0.32B |
$3.86B |
8.76% |
| 2023-03-31 |
$0.31B |
$3.76B |
8.85% |
| 2022-12-31 |
$0.30B |
$3.61B |
8.56% |
| 2022-09-30 |
$0.28B |
$3.34B |
7.93% |
| 2022-06-30 |
$0.28B |
$3.39B |
8.02% |
| 2022-03-31 |
$0.28B |
$3.55B |
8.44% |
| 2021-12-31 |
$0.28B |
$3.65B |
8.62% |
| 2021-09-30 |
$0.27B |
$3.13B |
8.81% |
| 2021-06-30 |
$0.24B |
$3.09B |
7.90% |
| 2021-03-31 |
$0.20B |
$3.04B |
6.85% |
| 2020-12-31 |
$0.16B |
$3.05B |
5.34% |
| 2020-09-30 |
$0.16B |
$2.88B |
5.47% |
| 2020-06-30 |
$0.17B |
$2.94B |
5.98% |
| 2020-03-31 |
$0.18B |
$2.96B |
6.82% |
| 2019-12-31 |
$0.20B |
$2.77B |
8.15% |
| 2019-09-30 |
$0.21B |
$2.35B |
9.12% |
| 2019-06-30 |
$0.19B |
$2.35B |
8.78% |
| 2019-03-31 |
$0.18B |
$2.24B |
9.07% |
| 2018-12-31 |
$0.18B |
$2.13B |
9.35% |
| 2018-09-30 |
$0.10B |
$1.89B |
5.24% |
| 2018-06-30 |
$0.09B |
$1.81B |
4.88% |
| 2018-03-31 |
$0.08B |
$1.83B |
4.39% |
| 2017-12-31 |
$0.08B |
$1.95B |
4.12% |
| 2017-09-30 |
$0.15B |
$1.96B |
8.03% |
| 2017-06-30 |
$0.16B |
$1.91B |
8.75% |
| 2017-03-31 |
$0.15B |
$1.84B |
8.54% |
| 2016-12-31 |
$0.16B |
$1.81B |
8.77% |
| 2016-09-30 |
$0.15B |
$1.80B |
8.41% |
| 2016-06-30 |
$0.11B |
$1.72B |
6.37% |
| 2016-03-31 |
$0.12B |
$1.74B |
6.67% |
| 2015-12-31 |
$0.10B |
$1.73B |
5.69% |
| 2015-09-30 |
$0.07B |
$1.84B |
3.67% |
| 2015-06-30 |
$0.06B |
$1.82B |
3.31% |
| 2015-03-31 |
$0.06B |
$1.77B |
2.91% |
| 2014-12-31 |
$0.06B |
$1.87B |
2.92% |
| 2014-09-30 |
$0.07B |
$1.91B |
3.33% |
| 2014-06-30 |
$0.08B |
$2.00B |
3.87% |
| 2014-03-31 |
$0.08B |
$2.03B |
4.33% |
| 2013-12-31 |
$0.08B |
$1.99B |
4.25% |
| 2013-09-30 |
$0.06B |
$1.94B |
3.13% |
| 2013-06-30 |
$0.08B |
$1.80B |
4.46% |
| 2013-03-31 |
$0.07B |
$1.81B |
3.77% |
| 2012-12-31 |
$0.08B |
$1.86B |
4.33% |
| 2012-09-30 |
$0.10B |
$1.80B |
5.89% |
| 2012-06-30 |
$0.08B |
$1.75B |
4.85% |
| 2012-03-31 |
$0.10B |
$1.80B |
5.58% |
| 2011-12-31 |
$0.09B |
$1.71B |
5.49% |
| 2011-09-30 |
$0.08B |
$1.67B |
5.01% |
| 2011-06-30 |
$0.09B |
$1.70B |
5.79% |
| 2011-03-31 |
$0.09B |
$1.62B |
6.44% |
| 2010-12-31 |
$0.10B |
$1.55B |
7.41% |
| 2010-09-30 |
$0.11B |
$1.28B |
9.26% |
| 2010-06-30 |
$0.10B |
$1.14B |
8.61% |
| 2010-03-31 |
$0.09B |
$1.16B |
7.83% |
| 2009-12-31 |
$0.08B |
$1.17B |
7.29% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$11.984B |
$2.965B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
